An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the overall response rate (ORR) and safety when
treating patients with myelodysplastic syndrome with decitabine. Decitabine is to be
administered as long as there is evidence of clinical benefit.